117,000 doses of Pfizer's COVID-19 vaccine supplied by the COVAX Facility will arrive in Korea on the 26th, and attention is focused on whether vaccination is possible immediately. COVAX Facility's Pfizer vaccine is highly likely to greatly simplify the assay method, as it is introduced in Korea through a special import rather than a domestic official license. The MFDS is known to be planning to discuss this with the KCDA in the near future.

According to the MFDS and the KCDA on the 22nd, consultations will be held soon to test the Pfizer vaccine supplied from COVAX.

The MFDS approves national lot release by conducting an inspection for quality verification on vaccines that have been app